tm
Seeing Is Believing
tm
Seeing Is Believing
PRME is currently covered by 7 analysts with an average price target of $8.19. This is a potential upside of $6.57 (405.56%) from yesterday's end of day stock price of $1.62.
Prime Medicine, Common Stock's activity chart (see below) currently has 5 price targets and 17 ratings on display. The stock rating distribution of PRME is 76.92% BUY and 23.08% HOLD.
Analysts average stock forecasts to be materialized ratio is 20.83% with an average time for these price targets to be met of 13 days.
Highest price target for PRME is $15, Lowest price target is $3, average price target is $14.33.
Most recent stock forecast was given by DEBJIT CHATTOPADHYAY from GUGGENHEIM on 03-Dec-2024. First documented stock forecast 14-Nov-2022.
Currently out of the existing stock ratings of PRME, 10 are a BUY (76.92%), 3 are a HOLD (23.08%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$24
6 months 14 days ago
(03-Dec-2024)
0/1 (0%)
$8.93 (59.26%)
Buy
$15
$13.54 (927.40%)
$26
1 years 1 months 4 days ago
(13-May-2024)
0/3 (0%)
$8.58 (133.64%)
Hold
$9
$7.54 (516.44%)
$18
1 years 5 months 1 days ago
(16-Jan-2024)
1/2 (50%)
$1.99 (28.39%)
42
Hold
$19
$17.54 (1201.37%)
$21
1 years 10 months 3 days ago
(14-Aug-2023)
1/3 (33.33%)
$6.77 (55.36%)
10
What is PRME (Prime Medicine, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on PRME (Prime Medicine, Common Stock) with a proven track record?
Which analyst has the current lower performing score on PRME (Prime Medicine, Common Stock) with a proven track record?
Which analyst has the most public recommendations on PRME (Prime Medicine, Common Stock)?
Which analyst is the currently most bullish on PRME (Prime Medicine, Common Stock)?
Which analyst is the currently most reserved on PRME (Prime Medicine, Common Stock)?
